Logo for Protagonist Therapeutics Inc

Protagonist Therapeutics Investor Relations Material

Latest events

Logo for Protagonist Therapeutics Inc

Status Update

Protagonist Therapeutics
Logo for Protagonist Therapeutics

Status Update

30 Jun, 2025
Logo for Protagonist Therapeutics

Status Update

2 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Protagonist Therapeutics Inc

Access all reports
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative peptide-based therapeutic drugs aimed at addressing unmet medical needs. The company's focus encompasses a broad range of diseases, with a particular emphasis on rare and prevalent conditions where existing treatments are limited or inadequate. Protagonist Therapeutics' technology platform has produced a pipeline of promising drug candidates, including peptide-based drugs for hematology and blood disorders, as well as inflammatory and immunomodulatory diseases.